Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Igenica Biotherapeutics
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2017.
French biotechs Servier and ILTOO sign an option agreement for the latter's IL-2 inhibitor for lupus, while Korean biotechs LegoChem and Bridge will team up in idiopathic pulmonary fibrosis.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Recent executive-level hires and director appointments at venture capital firms and biopharma, medtech, and diagnostics start-ups.
Drug Discovery Tools
- Large Molecule